GlassScriptPhysician profile
Kushkaran Kaur
NPI 1023639572
$5,384.56
in general payments reported to CMS, 2019-2025
11 companies · $3,991 in 2025
The $3,991 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $120 · 2023: $14.52 · 2024: $1,126 · 2025: $3,991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,358 · Food and Beverage: $1,773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,358.12 |
| Food and Beverage | $1,772.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $2,157.67 | 2025 | |
| Arthrex, INC. | $1,082.01 | 2025 | |
| Medshape, INC. | $1,047.59 | 2024 | Dynanail, Dynanail Mini |
| Stryker Corporation | $506.68 | 2024-2025 | Flexband, Inbone, Vitoss |
| Polaris Technology Solutions LLC | $209.94 | 2025 | |
| Acumed LLC | $118.43 | 2022-2023 | Acumed |
| Medical Device Business Services, INC. | $96.42 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $70.22 | 2024-2025 | Iovera, Exparel |
| Trilliant Surgical LLC. | $42.35 | 2024 | Minimally Invasive Bunion Plate, Left |
| Depuy Synthes Sales INC. | $37.29 | 2021 | |
| Kci USA, INC. | $15.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kushkaran Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.